JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kien, G. A.
Right arrow Articles by Sherrod, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kien, G. A.
Right arrow Articles by Sherrod, T. R.
Journal of Pharmacology And Experimental Therapeutics, Vol. 125, Issue 3, 213-217, 1959
Copyright © 1959 by American Society for Pharmacology and Experimental Therapeutics


THE EFFECT OF N-METHYL-N-CINNAMYL-2-PHENYL-PROPYLAMINE (MRD-255) ON CORONARY CIRCULATION, CARDIAC WORK AND MYOCARDIAL OXYGEN UTILIZATION IN THE DOG

Gerald A. Kien 1 and Theodore R. Sherrod 1

1 Department of Pharmacology, University of Illinois College of Medicine, Chicago

The effects of N-methyl-N-cinnamyl-2-phenylpropylamine (MRD-255) and papaverine on coronary blood flow were studied in the open-chest anesthetized dog, utilizing both the technique of coronary sinus outflow and coronary artery inflow. Cardiac work and cardiac oxygen utilization were determined.

Intravenous and intraarterial administration of MRD-255 resulted in an increase in coronary blood flow of equal magnitude but longer duration than that produced by equal doses of papaverine. In addition, there was no fall in blood pressure with intravenous administration of MRD-255, as contrasted with the marked hypotensive response to papaverine at doses above 1 mg/kg body weight.

Both MRD-255 and papaverine resulted in an increased coronary blood flow in the absence of significant changes in either cardiac work or cardiac oxygen utilization. The oxygen concentration of the coronary venous blood was greatly increased during the period of the increased coronary blood flow, indicating an oxygen supply far in excess of the metabolic demands of the myocardium.

Submitted on September 29, 1958







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1959 by the American Society for Pharmacology and Experimental Therapeutics.